U.S., Jan. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07323238) titled 'HONG KONG CARDIOGENIC SHOCK INITIATIVE' on Dec. 03, 2025.
Brief Summary: Acute myocardial infarction complicated by cardiogenic shock (AMI-CS) is a severe condition with high mortality. Early revascularization and Impella device (Abiomed) support improve outcomes. Observational studies like the National Cardiogenic Shock Initiative (NCSI), Inova-Shock registry, and J-PVAD (Japan registry for percutaneous ventricular assist device) registry emphasize the importance of structured care systems when using mechanical circulatory support (MCS).
Following the release of the Danger Shock trial, MCS use is expected to rise. Hospitals will ne...